The global Angiotensin II receptor blockers Market was valued at USD 7.87 Billion in 2020 and is projected to reach USD 10.34 Billion by 2028, with a compound annual growth rate (CAGR) of 3.51%. These drugs block the renin-angiotensin system, leading to a decrease in blood pressure and inhibition of various angiotensin-related pathological processes, such as vasoconstriction, apoptosis, inflammation, fibrosis, and coagulation. As a result, ARB drugs are commonly used to treat conditions such as coronary heart disease, heart failure, diabetic nephropathy, and hypertension.
https://www.reportsanddata.com..../report-detail/angio